IRIS Accounts Production v26.1.10.61 07942286 Board of Directors 1.3.25 28.2.26 28.2.26 false true false false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh079422862025-02-28079422862026-02-28079422862025-03-012026-02-28079422862024-02-29079422862024-03-012025-02-28079422862025-02-2807942286ns15:EnglandWales2025-03-012026-02-2807942286ns14:PoundSterling2025-03-012026-02-2807942286ns10:Director12025-03-012026-02-2807942286ns10:PrivateLimitedCompanyLtd2025-03-012026-02-2807942286ns10:SmallEntities2025-03-012026-02-2807942286ns10:AuditExempt-NoAccountantsReport2025-03-012026-02-2807942286ns10:SmallCompaniesRegimeForDirectorsReport2025-03-012026-02-2807942286ns10:SmallCompaniesRegimeForAccounts2025-03-012026-02-2807942286ns10:FullAccounts2025-03-012026-02-280794228612025-03-012026-02-2807942286ns10:Director22025-03-012026-02-2807942286ns10:CompanySecretary12025-03-012026-02-2807942286ns10:RegisteredOffice2025-03-012026-02-2807942286ns5:CurrentFinancialInstruments2026-02-2807942286ns5:CurrentFinancialInstruments2025-02-2807942286ns5:ShareCapital2026-02-2807942286ns5:ShareCapital2025-02-2807942286ns5:SharePremium2026-02-2807942286ns5:SharePremium2025-02-2807942286ns5:RetainedEarningsAccumulatedLosses2026-02-2807942286ns5:RetainedEarningsAccumulatedLosses2025-02-2807942286ns5:IntangibleAssetsOtherThanGoodwill2025-03-012026-02-2807942286ns5:DevelopmentCostsCapitalisedDevelopmentExpenditure2025-03-012026-02-2807942286ns5:FurnitureFittings2025-03-012026-02-2807942286ns5:ComputerEquipment2025-03-012026-02-2807942286ns5:IntangibleAssetsOtherThanGoodwill2025-02-2807942286ns5:IntangibleAssetsOtherThanGoodwill2026-02-2807942286ns5:IntangibleAssetsOtherThanGoodwill2025-02-2807942286ns5:FurnitureFittings2025-02-2807942286ns5:ComputerEquipment2025-02-2807942286ns5:FurnitureFittings2026-02-2807942286ns5:ComputerEquipment2026-02-2807942286ns5:FurnitureFittings2025-02-2807942286ns5:ComputerEquipment2025-02-2807942286ns5:WithinOneYearns5:CurrentFinancialInstruments2026-02-2807942286ns5:WithinOneYearns5:CurrentFinancialInstruments2025-02-2807942286ns5:RetainedEarningsAccumulatedLosses2025-02-2807942286ns5:SharePremium2025-02-2807942286ns5:RetainedEarningsAccumulatedLosses2025-03-012026-02-2807942286ns10:Director112025-02-2807942286ns10:Director112024-02-2907942286ns10:Director112025-03-012026-02-2807942286ns10:Director112024-03-012025-02-2807942286ns10:Director112026-02-2807942286ns10:Director112025-02-28
REGISTERED NUMBER: 07942286 (England and Wales)















UNAUDITED FINANCIAL STATEMENTS FOR THE YEAR ENDED 28 FEBRUARY 2026

FOR

HONEYDEW HEALTH LIMITED

HONEYDEW HEALTH LIMITED (REGISTERED NUMBER: 07942286)






CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 28 FEBRUARY 2026




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 4


HONEYDEW HEALTH LIMITED

COMPANY INFORMATION
FOR THE YEAR ENDED 28 FEBRUARY 2026







DIRECTORS: Miss M Nielsen
Mr M Hagelin





SECRETARY: Miss M Nielsen





REGISTERED OFFICE: 4 Crown Place
London
EC2A 4BT





REGISTERED NUMBER: 07942286 (England and Wales)





ACCOUNTANTS: Xeinadin
1st Floor
Isabella House
12 Union Court
Richmond upon Thames
London
TW9 1AA

HONEYDEW HEALTH LIMITED (REGISTERED NUMBER: 07942286)

BALANCE SHEET
28 FEBRUARY 2026

28.2.26 28.2.25
Notes £    £   
FIXED ASSETS
Intangible assets 4 86,168 43,041
Property, plant and equipment 5 5,732 9,023
91,900 52,064

CURRENT ASSETS
Debtors 6 163,280 219,638
Cash at bank 43,040 208,390
206,320 428,028
CREDITORS
Amounts falling due within one year 7 (219,077 ) (230,148 )
NET CURRENT (LIABILITIES)/ASSETS (12,757 ) 197,880
TOTAL ASSETS LESS CURRENT
LIABILITIES

79,143

249,944

CAPITAL AND RESERVES
Called up share capital 1,398 1,398
Share premium 8 118,702 118,702
Retained earnings 8 (40,957 ) 129,844
SHAREHOLDERS' FUNDS 79,143 249,944

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 28 February 2026.

The members have not required the company to obtain an audit of its financial statements for the year ended 28 February 2026 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

HONEYDEW HEALTH LIMITED (REGISTERED NUMBER: 07942286)

BALANCE SHEET - continued
28 FEBRUARY 2026


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 2 October 2026 and were signed on its behalf by:





Miss M Nielsen - Director


HONEYDEW HEALTH LIMITED (REGISTERED NUMBER: 07942286)

NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 28 FEBRUARY 2026

1. STATUTORY INFORMATION

Honeydew Health Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Revenue is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Intangible assets
Intangible assets are initially measured at cost. After initial recognition, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses.

App Development costs are being amortised evenly over their estimated useful life of five years.

Development costs
Capitalised development costs are amortised over their estimated useful life of five years.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Fixtures and fittings - 25% on cost
Computer equipment - 20% on cost

Hire purchase and leasing commitments
Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the lease.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 7 (2025 - 7 ) .

HONEYDEW HEALTH LIMITED (REGISTERED NUMBER: 07942286)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 28 FEBRUARY 2026

4. INTANGIBLE FIXED ASSETS
Other
intangible
assets
£   
COST
At 1 March 2025 217,619
Additions 67,381
At 28 February 2026 285,000
AMORTISATION
At 1 March 2025 174,578
Charge for year 24,254
At 28 February 2026 198,832
NET BOOK VALUE
At 28 February 2026 86,168
At 28 February 2025 43,041

5. PROPERTY, PLANT AND EQUIPMENT
Fixtures
and Computer
fittings equipment Totals
£    £    £   
COST
At 1 March 2025 485 24,402 24,887
Additions - 1,514 1,514
At 28 February 2026 485 25,916 26,401
DEPRECIATION
At 1 March 2025 485 15,379 15,864
Charge for year - 4,805 4,805
At 28 February 2026 485 20,184 20,669
NET BOOK VALUE
At 28 February 2026 - 5,732 5,732
At 28 February 2025 - 9,023 9,023

6. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
28.2.26 28.2.25
£    £   
Trade debtors 118,832 185,238
Other debtors 44,448 34,400
163,280 219,638

HONEYDEW HEALTH LIMITED (REGISTERED NUMBER: 07942286)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 28 FEBRUARY 2026

7. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
28.2.26 28.2.25
£    £   
Trade creditors 88,679 45,106
Taxation and social security 32,205 54,499
Other creditors 98,193 130,543
219,077 230,148

8. RESERVES
Retained Share
earnings premium Totals
£    £    £   

At 1 March 2025 129,844 118,702 248,546
Deficit for the year (170,801 ) (170,801 )
At 28 February 2026 (40,957 ) 118,702 77,745

9. DIRECTORS' ADVANCES, CREDITS AND GUARANTEES

The following advances and credits to a director subsisted during the years ended 28 February 2026 and 28 February 2025:

28.2.26 28.2.25
£    £   
Miss M Nielsen
Balance outstanding at start of year 14,577 18,288
Amounts advanced 329 -
Amounts repaid - (3,711 )
Amounts written off - -
Amounts waived - -
Balance outstanding at end of year 14,906 14,577

It is confirmed that the director's current account is debited with personal transactions and credited with director's remuneration as well as dividends.

The loan is unsecured, interest is charged at 2.25% and no repayment terms have been agreed.

10. ULTIMATE CONTROLLING PARTY

The controlling party is Miss M Nielsen.